Hopefully one of COVID’s legacies will be widespread adoption of remote patient monitoring using biosensors. And one of the biggest beneficiaries could be patients on opioid addiction therapy. Our client Pneumowave are trialing a system in projects led by Dundee and Kings that would provide alerts of potentially fatal respiratory distress to carers.